Type
1.
Hsieh C-L, Hsiao P-F. Diagnosis and Treatment of Leprosy in Taiwan during the COVID-19 Pandemic: A Retrospective Study in a Tertiaty Center. Diagnostics (Basel, Switzerland) [Internet]. 2023;13(24):1-12. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10742743/pdf/diagnostics-13-03655.pdf
Type
1.
Duarte VMS, Bonazza DSS, Lino-Dos-Santos-Franco A, Fontes CJF, Damazo AS. Application of a physiotherapeutic protocol associated with photobiomodulation for the treatment of leprosy patients. Lasers in medical science. 2023;39(1):12.
Type
1.
Dogra S, Jain S, Sharma A, Chhabra S, Narang T. (MIP) Vaccine: Pharmacology, Indication, Dosing Schedules, Administration, and Side Effects in Clinical Practice. Indian dermatology online journal [Internet]. 2023;14(6):753-61. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10718117/pdf/IDOJ-14-753.pdf
Type
1.
Vicentini CB, Contini C. Historical account of clinical observations on leprosy and related manifestations in the Comacchio area, Italy, in the XIX century. Le infezioni in medicina [Internet]. 2023;31(4):591-9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10705852/pdf/1124-9390_31_4_2023_591-599.pdf
Type
1.
Moraes ACCG, da Luz RCFV, Fernandes ALM, Barbosa MXS, de Andrade LV, Armstrong A da C, et al. Association of PTX3 gene polymorphisms and PTX3 plasma levels with leprosy susceptibility. BMC infectious diseases [Internet]. 2023;23(1):1-7. Available from: https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-023-08862-0.pdf
Type
1.
Singh I, Pathak VK, Lavania M, Ahuja M, Sharma R, Narang T, et al. Genomic characterization of Mycobacterium lepromatosis from ENL patients from India. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases [Internet]. 2023;:1-11. Available from: https://pdf.sciencedirectassets.com/272223/1-s2.0-S1567134823X00094/1-s2.0-S1567134823001351/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjELH%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJGMEQCIFy8kyi4cWoAoZSB6C1XaXXfN5iW%2B%2BPQyWwjwBYlT0KCAiAdFLfJ20ho
Type
1.
Lopes-Luz L, Saavedra DP, Fogaça MBT, Bührer-Sékula S, Stefani MM de A. Challenges and advances in serological and molecular tests to aid leprosy diagnosis. Experimental biology and medicine (Maywood, N.J.) [Internet]. 2023;:15353702231209422. Available from: https://journals.sagepub.com/doi/reader/10.1177/15353702231209422
Type
1.
de Souza FG, da Silva MB, de Araújo GS, Silva CS, Pinheiro AHG, Cáceres-Durán M Ángel, et al. Whole mitogenome sequencing uncovers a relation between mitochondrial heteroplasmy and leprosy severity. Human genomics [Internet]. 2023;17(1):1-15. Available from: https://humgenomics.biomedcentral.com/counter/pdf/10.1186/s40246-023-00555-8.pdf
Type
1.
Xu L, Jin G, Li X, Shao Y, Li Y, Zhang L. Self-Care Ability and Life Quality of Cured Leprosy Patients: The Mediating Effects of Social Support. Healthcare (Basel, Switzerland) [Internet]. 2023;11(23):1-14. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10706674/pdf/healthcare-11-03059.pdf
Type
1.
Singh S, Sharma D, Gautam S, Arora M, Bisht D. Exploring the Cell Wall and Secretory Proteins of Mycobacterium leprae as Biomarkers. Protein and peptide letters. 2023;.